(Q53167302)
Statements
Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis. (English)
D Revicki
M K Willian
J-H Saurat
K A Papp
J-P Ortonne
C Sexton
A Camez
28 November 2007
158
3
549-557
1 reference